{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:49:06Z","timestamp":1782182946598,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment options for chronic thromboembolic pulmonary hypertension (CTEPH) that is not amenable to thromboendarterectomy or is recurrent\/persistent after thromboendarterectomy (inoperable CTEPH) include pulmonary vasodilators or balloon pulmonary angioplasty (BPA). We compared efficacy and safety outcomes of BPA with or without pulmonary vasodilators to pulmonary vasodilator therapy alone in patients with inoperable CTEPH. Observational and randomized trial data reporting outcomes for &gt;5 patients with inoperable CTEPH were sought. Single-arm random effects meta-analyses were performed. The primary outcome was change in six-minute walk distance (6MWD). Secondary outcomes included safety; World Health Organization functional class (WHO FC); and change in mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance (PVR), and cardiac index. Thirty-four studies with 1604 patients were eligible for analyses. Both treatments resulted in significant improvement in 6MWD (71.0 meters, 95% CI: 47.4\u201394.5 meters with BPA versus 47.8 meters, 95% CI: 34.5\u201361.2 meters with pulmonary vasodilators), PVR [\u22123.1 Wood Units (WU), 95% CI: \u22124.9 to \u22121.4 WU versus \u22121.6 WU, 95% CI: \u22122.4 to \u22120.8 WU] and mPAP (\u221214.8\u2009mmHg, 95% CI: \u221218.2 to \u221211.5\u2009mmHg versus \u22124.9\u2009mmHg, 95% CI: \u22126.9 to \u22122.8\u2009mmHg). Cardiac index was similar and most patients were WHO FC II and III after their respective interventions. More complications occurred in the BPA arm. In conclusion, BPA and pulmonary vasodilators both improve 6MWD and hemodynamics in patients with inoperable CTEPH. While BPA may offer greater functional and hemodynamic improvements, this technique carries the accompanying risks of an invasive procedure.<\/jats:p>","DOI":"10.1038\/s41598-020-65697-4","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T10:03:14Z","timestamp":1591005794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparison of Balloon Pulmonary Angioplasty and Pulmonary Vasodilators for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis"],"prefix":"10.1038","volume":"10","author":[{"given":"Rajat","family":"Kalra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thenappan","family":"Thenappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Raveendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pritzker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha Z.","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt W.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"65697_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMra0910203","volume":"364","author":"G Piazza","year":"2011","unstructured":"Piazza, G. & Goldhaber, S. Z. Chronic thromboembolic pulmonary hypertension. The New England journal of medicine 364, 351\u2013360, https:\/\/doi.org\/10.1056\/NEJMra0910203 (2011).","journal-title":"The New England journal of medicine"},{"key":"65697_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie, N. et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European heart journal 37, 67\u2013119, https:\/\/doi.org\/10.1093\/eurheartj\/ehv317 (2016).","journal-title":"European heart journal"},{"key":"65697_CR3","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","volume":"62","author":"NH Kim","year":"2013","unstructured":"Kim, N. H. et al. Chronic thromboembolic pulmonary hypertension. Journal of the American College of Cardiology 62, D92\u2013D99 (2013).","journal-title":"Journal of the American College of Cardiology"},{"key":"65697_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jtcvs.2009.12.056","volume":"141","author":"DH Freed","year":"2011","unstructured":"Freed, D. H. et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. The Journal of thoracic and cardiovascular surgery 141, 383\u2013387, https:\/\/doi.org\/10.1016\/j.jtcvs.2009.12.056 (2011).","journal-title":"The Journal of thoracic and cardiovascular surgery"},{"key":"65697_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","volume":"141","author":"E Mayer","year":"2011","unstructured":"Mayer, E. et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. The Journal of thoracic and cardiovascular surgery 141, 702\u2013710, https:\/\/doi.org\/10.1016\/j.jtcvs.2010.11.024 (2011).","journal-title":"The Journal of thoracic and cardiovascular surgery"},{"key":"65697_CR6","doi-asserted-by":"publisher","first-page":"pii: 160119","DOI":"10.1183\/16000617.0119-2016","volume":"26","author":"I Lang","year":"2017","unstructured":"Lang, I. et al. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. European respiratory review: an official journal of the European Respiratory Society 26, pii: 160119, https:\/\/doi.org\/10.1183\/16000617.0119-2016 (2017).","journal-title":"European respiratory review: an official journal of the European Respiratory Society"},{"key":"65697_CR7","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.jacc.2018.04.009","volume":"71","author":"E Mahmud","year":"2018","unstructured":"Mahmud, E. et al. Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease. Journal of the American College of Cardiology 71, 2468\u20132486, https:\/\/doi.org\/10.1016\/j.jacc.2018.04.009 (2018).","journal-title":"Journal of the American College of Cardiology"},{"key":"65697_CR8","doi-asserted-by":"publisher","first-page":"e004029","DOI":"10.1161\/circoutcomes.117.004029","volume":"10","author":"A Ogawa","year":"2017","unstructured":"Ogawa, A. et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry. Circulation. Cardiovascular quality and outcomes 10, e004029, https:\/\/doi.org\/10.1161\/circoutcomes.117.004029 (2017).","journal-title":"Circulation. Cardiovascular quality and outcomes"},{"key":"65697_CR9","doi-asserted-by":"publisher","first-page":"e1801915","DOI":"10.1183\/13993003.01915-2018","volume":"53","author":"NH Kim","year":"2019","unstructured":"Kim, N. H. et al. Chronic thromboembolic pulmonary hypertension. The European respiratory journal 53, e1801915, https:\/\/doi.org\/10.1183\/13993003.01915-2018 (2019).","journal-title":"The European respiratory journal"},{"key":"65697_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa1209657","volume":"369","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani, H. A. et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. The New England journal of medicine 369, 319\u2013329, https:\/\/doi.org\/10.1056\/NEJMoa1209657 (2013).","journal-title":"The New England journal of medicine"},{"key":"65697_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/s2213-2600(17)30305-3","volume":"5","author":"HA Ghofrani","year":"2017","unstructured":"Ghofrani, H. A. et al. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. The Lancet. Respiratory medicine 5, 785\u2013794, https:\/\/doi.org\/10.1016\/s2213-2600(17)30305-3 (2017).","journal-title":"The Lancet. Respiratory medicine"},{"key":"65697_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s2213-2600(18)30367-9","volume":"7","author":"R Sadushi-Kolici","year":"2019","unstructured":"Sadushi-Kolici, R. et al. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. The Lancet. Respiratory medicine 7, 239\u2013248, https:\/\/doi.org\/10.1016\/s2213-2600(18)30367-9 (2019).","journal-title":"The Lancet. Respiratory medicine"},{"key":"65697_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1096\/fj.07-9492LSF","volume":"22","author":"ME Falagas","year":"2008","unstructured":"Falagas, M. E., Pitsouni, E. I., Malietzis, G. A. & Pappas, G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 22, 338\u2013342, https:\/\/doi.org\/10.1096\/fj.07-9492LSF (2008).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"65697_CR14","unstructured":"Wells GA et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (2019)."},{"key":"65697_CR15","doi-asserted-by":"publisher","unstructured":"Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed.) 366, l4898, https:\/\/doi.org\/10.1136\/bmj.l4898 (2019).","DOI":"10.1136\/bmj.l4898"},{"key":"65697_CR16","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar, M. K., Torri, V. & Stewart, L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in medicine 17, 2815\u20132834 (1998).","journal-title":"Statistics in medicine"},{"key":"65697_CR17","doi-asserted-by":"crossref","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed.) 327, 557-560, 10.1136\/bmj.327.7414.557 (2003).","DOI":"10.1136\/bmj.327.7414.557"},{"key":"65697_CR18","doi-asserted-by":"crossref","unstructured":"Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 315, 629-634 (1997).","DOI":"10.1136\/bmj.315.7109.629"},{"key":"65697_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval, S. & Tweedie, R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455\u2013463 (2000).","journal-title":"Biometrics"},{"key":"65697_CR20","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283, 2008\u20132012 (2000).","journal-title":"Jama"},{"key":"65697_CR21","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing, https:\/\/www.R-project.org\/ (2018)."},{"key":"65697_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/01.CIR.103.1.10","volume":"103","author":"JA Feinstein","year":"2001","unstructured":"Feinstein, J. A., Goldhaber, S. Z., Lock, J. E., Ferndandes, S. M. & Landzberg, M. J. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 103, 10\u201313 (2001).","journal-title":"Circulation"},{"key":"65697_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.5603\/KP.a2017.0091","volume":"75","author":"M Kurzyna","year":"2017","unstructured":"Kurzyna, M. et al. Changing the strategy of balloon pulmonary angioplasty resulted in a reduced complication rate in patients with chronic thromboembolic pulmonary hypertension. A single-centre European experience. Kardiologia polska 75, 645\u2013654, https:\/\/doi.org\/10.5603\/KP.a2017.0091 (2017).","journal-title":"Kardiologia polska"},{"key":"65697_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/joic.12387","volume":"30","author":"M Roik","year":"2017","unstructured":"Roik, M. et al. Refined balloon pulmonary angioplasty-A therapeutic option in very elderly patients with chronic thromboembolic pulmonary hypertension. Journal of interventional cardiology 30, 249\u2013255, https:\/\/doi.org\/10.1111\/joic.12387 (2017).","journal-title":"Journal of interventional cardiology"},{"key":"65697_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10554-016-0985-y","volume":"33","author":"Y Yamasaki","year":"2017","unstructured":"Yamasaki, Y. et al. Balloon pulmonary angioplasty improves interventricular dyssynchrony in patients with inoperable chronic thromboembolic pulmonary hypertension: a cardiac MR imaging study. The international journal of cardiovascular imaging 33, 229\u2013239, https:\/\/doi.org\/10.1007\/s10554-016-0985-y (2017).","journal-title":"The international journal of cardiovascular imaging"},{"key":"65697_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.healun.2017.12.006","volume":"37","author":"SD Kriechbaum","year":"2018","unstructured":"Kriechbaum, S. D. et al. N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 37, 639\u2013646, https:\/\/doi.org\/10.1016\/j.healun.2017.12.006 (2018).","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"key":"65697_CR27","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.3346\/jkms.2018.33.e24","volume":"33","author":"W Kwon","year":"2018","unstructured":"Kwon, W. et al. Impact of Balloon Pulmonary Angioplasty on Hemodynamics and Clinical Outcomes in Patients with Chronic Thromboembolic Pulmonary Hypertension: the Initial Korean Experience. Journal of Korean medical science 33, e24, https:\/\/doi.org\/10.3346\/jkms.2018.33.e24 (2018).","journal-title":"Journal of Korean medical science"},{"key":"65697_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10554-017-1296-7","volume":"34","author":"H Moriyama","year":"2018","unstructured":"Moriyama, H. et al. The clinical value of assessing right ventricular diastolic function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. The international journal of cardiovascular imaging 34, 875\u2013882, https:\/\/doi.org\/10.1007\/s10554-017-1296-7 (2018).","journal-title":"The international journal of cardiovascular imaging"},{"key":"65697_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/ggi.13224","volume":"18","author":"Y Yamagata","year":"2018","unstructured":"Yamagata, Y. et al. Balloon pulmonary angioplasty is effective for treating peripheral-type chronic thromboembolic pulmonary hypertension in elderly patients. Geriatrics & gerontology international 18, 678\u2013684, https:\/\/doi.org\/10.1111\/ggi.13224 (2018).","journal-title":"Geriatrics & gerontology international"},{"issue":"5","key":"65697_CR30","doi-asserted-by":"publisher","first-page":"1802095","DOI":"10.1183\/13993003.02095-2018","volume":"53","author":"Philippe Brenot","year":"2019","unstructured":"Brenot, P. et al. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 1802095, https:\/\/doi.org\/10.1183\/13993003.02095-2018 (2019).","journal-title":"European Respiratory Journal"},{"key":"65697_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.rec.2018.02.020","volume":"72","author":"M Velazquez","year":"2019","unstructured":"Velazquez, M. et al. Balloon Pulmonary Angioplasty for Inoperable Patients With Chronic Thromboembolic Pulmonary Hypertension. Observational Study in a Referral Unit. Revista espanola de cardiologia (English ed.) 72, 224\u2013232, https:\/\/doi.org\/10.1016\/j.rec.2018.02.020 (2019).","journal-title":"Revista espanola de cardiologia (English ed.)"},{"key":"65697_CR32","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1164\/rccm.200210-1157BC","volume":"167","author":"HA Ghofrani","year":"2003","unstructured":"Ghofrani, H. A. et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. American journal of respiratory and critical care medicine 167, 1139\u20131141, https:\/\/doi.org\/10.1164\/rccm.200210-1157BC (2003).","journal-title":"American journal of respiratory and critical care medicine"},{"key":"65697_CR33","first-page":"618","volume":"5","author":"L Scelsi","year":"2004","unstructured":"Scelsi, L. et al. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions. Italian heart journal: official journal of the Italian Federation of Cardiology 5, 618\u2013623 (2004).","journal-title":"Italian heart journal: official journal of the Italian Federation of Cardiology"},{"key":"65697_CR34","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1378\/chest.128.4.2599","volume":"128","author":"D Bonderman","year":"2005","unstructured":"Bonderman, D. et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 128, 2599\u20132603, https:\/\/doi.org\/10.1378\/chest.128.4.2599 (2005).","journal-title":"Chest"},{"key":"65697_CR35","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1378\/chest.128.4.2363","volume":"128","author":"MM Hoeper","year":"2005","unstructured":"Hoeper, M. M. et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 128, 2363\u20132367, https:\/\/doi.org\/10.1378\/chest.128.4.2363 (2005).","journal-title":"Chest"},{"key":"65697_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1183\/09031936.06.00135905","volume":"28","author":"RJ Hughes","year":"2006","unstructured":"Hughes, R. J. et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. The European respiratory journal 28, 138\u2013143, https:\/\/doi.org\/10.1183\/09031936.06.00135905 (2006).","journal-title":"The European respiratory journal"},{"key":"65697_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000092920","volume":"106","author":"CD Vizza","year":"2006","unstructured":"Vizza, C. D. et al. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study. Cardiology 106, 168\u2013173, https:\/\/doi.org\/10.1159\/000092920 (2006).","journal-title":"Cardiology"},{"key":"65697_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.healun.2006.12.014","volume":"26","author":"S Cabrol","year":"2007","unstructured":"Cabrol, S. et al. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 26, 357\u2013362, https:\/\/doi.org\/10.1016\/j.healun.2006.12.014 (2007).","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"key":"65697_CR39","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1183\/09031936.00039007","volume":"30","author":"F Reichenberger","year":"2007","unstructured":"Reichenberger, F. et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. The European respiratory journal 30, 922\u2013927, https:\/\/doi.org\/10.1183\/09031936.00039007 (2007).","journal-title":"The European respiratory journal"},{"key":"65697_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1157\/13096947","volume":"128","author":"J Segovia Cubero","year":"2007","unstructured":"Segovia Cubero, J. et al. Role of bosentan in patients with chronic venous thromboembolic pulmonary hypertension. Medicina clinica 128, 12\u201314 (2007).","journal-title":"Medicina clinica"},{"key":"65697_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000093322","volume":"74","author":"HJ Seyfarth","year":"2007","unstructured":"Seyfarth, H. J., Hammerschmidt, S., Pankau, H., Winkler, J. & Wirtz, H. Long-term bosentan in chronic thromboembolic pulmonary hypertension. Respiration; international review of thoracic diseases 74, 287\u2013292, https:\/\/doi.org\/10.1159\/000093322 (2007).","journal-title":"Respiration; international review of thoracic diseases"},{"key":"65697_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1538-7836.2007.02394.x","volume":"5","author":"N Skoro-Sajer","year":"2007","unstructured":"Skoro-Sajer, N. et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. Journal of thrombosis and haemostasis: JTH 5, 483\u2013489, https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02394.x (2007).","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"65697_CR43","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","volume":"52","author":"X Jais","year":"2008","unstructured":"Jais, X. et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. Journal of the American College of Cardiology 52, 2127\u20132134, https:\/\/doi.org\/10.1016\/j.jacc.2008.08.059 (2008).","journal-title":"Journal of the American College of Cardiology"},{"key":"65697_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.pupt.2007.01.008","volume":"21","author":"R Rossi","year":"2008","unstructured":"Rossi, R., Nuzzo, A., Lattanzi, A. & Coppi, F. & Modena, M. G. Sildenafil improves endothelial function in patients with pulmonary hypertension. Pulmonary pharmacology & therapeutics 21, 172\u2013177, https:\/\/doi.org\/10.1016\/j.pupt.2007.01.008 (2008).","journal-title":"Pulmonary pharmacology & therapeutics"},{"key":"65697_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1378\/chest.07-2681","volume":"134","author":"J Suntharalingam","year":"2008","unstructured":"Suntharalingam, J. et al. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 134, 229\u2013236, https:\/\/doi.org\/10.1378\/chest.07-2681 (2008).","journal-title":"Chest"},{"key":"65697_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF03086278","volume":"17","author":"MC Post","year":"2009","unstructured":"Post, M. C., Plokker, H. W., Kelder, J. C. & Snijder, R. J. Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension. Netherlands heart journal: monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 17, 329\u2013333 (2009).","journal-title":"Netherlands heart journal: monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation"},{"key":"65697_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejim.2008.03.008","volume":"20","author":"FG Vassallo","year":"2009","unstructured":"Vassallo, F. G. et al. Bosentan for patients with chronic thromboembolic pulmonary hypertension. European journal of internal medicine 20, 24\u201329, https:\/\/doi.org\/10.1016\/j.ejim.2008.03.008 (2009).","journal-title":"European journal of internal medicine"},{"key":"65697_CR48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1183\/09031936.00182909","volume":"36","author":"HA Ghofrani","year":"2010","unstructured":"Ghofrani, H. A. et al. Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. The European respiratory journal 36, 792\u2013799, https:\/\/doi.org\/10.1183\/09031936.00182909 (2010).","journal-title":"The European respiratory journal"},{"key":"65697_CR49","doi-asserted-by":"publisher","first-page":"204589401984643","DOI":"10.1177\/2045894019846433","volume":"9","author":"P Escribano-Subias","year":"2019","unstructured":"Escribano-Subias, P., Bendjenana, H., Curtis, P. S., Lang, I. & Noordegraaf, A. V. Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary circulation 9, 2045894019846433, https:\/\/doi.org\/10.1177\/2045894019846433 (2019).","journal-title":"Pulmonary circulation"},{"key":"65697_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcha.2019.02.004","volume":"22","author":"MCJ van Thor","year":"2019","unstructured":"van Thor, M. C. J., Ten Klooster, L., Snijder, R. J., Post, M. C. & Mager, J. J. Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. International journal of cardiology. Heart & vasculature 22, 163\u2013168, https:\/\/doi.org\/10.1016\/j.ijcha.2019.02.004 (2019).","journal-title":"International journal of cardiology. Heart & vasculature"},{"key":"65697_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.resinv.2017.04.004","volume":"55","author":"K Yamamoto","year":"2017","unstructured":"Yamamoto, K. et al. Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor. Respiratory investigation 55, 270\u2013275, https:\/\/doi.org\/10.1016\/j.resinv.2017.04.004 (2017).","journal-title":"Respiratory investigation"},{"key":"65697_CR52","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1253\/circj.70.1058","volume":"70","author":"HJ Reesink","year":"2006","unstructured":"Reesink, H. J. et al. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circulation Journal 70, 1058\u20131063 (2006).","journal-title":"Circulation Journal"},{"key":"65697_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.athoracsur.2012.04.004","volume":"94","author":"MM Madani","year":"2012","unstructured":"Madani, M. M. et al. Pulmonary endarterectomy: recent changes in a single institution\u2019s experience of more than 2,700 patients. The Annals of thoracic surgery 94, 97\u2013103 (2012).","journal-title":"The Annals of thoracic surgery"},{"key":"65697_CR54","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijcard.2016.09.036","volume":"225","author":"NS Bajaj","year":"2016","unstructured":"Bajaj, N. S. et al. Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses. International journal of cardiology 225, 128\u2013139, https:\/\/doi.org\/10.1016\/j.ijcard.2016.09.036 (2016).","journal-title":"International journal of cardiology"},{"key":"65697_CR55","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.athoracsur.2016.11.016","volume":"103","author":"R Kalra","year":"2017","unstructured":"Kalra, R. et al. Surgical Embolectomy for Acute Pulmonary Embolism: Systematic Review and Comprehensive Meta-Analyses. The Annals of thoracic surgery 103, 982\u2013990, https:\/\/doi.org\/10.1016\/j.athoracsur.2016.11.016 (2017).","journal-title":"The Annals of thoracic surgery"},{"key":"65697_CR56","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/circulationaha.115.016522","volume":"133","author":"M Delcroix","year":"2016","unstructured":"Delcroix, M. et al. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation 133, 859\u2013871, https:\/\/doi.org\/10.1161\/circulationaha.115.016522 (2016).","journal-title":"Circulation"},{"key":"65697_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hlc.2017.01.016","volume":"27","author":"K Phan","year":"2018","unstructured":"Phan, K., Jo, H. E., Xu, J. & Lau, E. M. Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-Analysis. Heart, lung & circulation 27, 89\u201398, https:\/\/doi.org\/10.1016\/j.hlc.2017.01.016 (2018).","journal-title":"Heart, lung & circulation"},{"key":"65697_CR58","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/clc.23212","volume":"42","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Balloon pulmonary angioplasty vs riociguat in patients with inoperable chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis. Clinical cardiology 42, 741\u2013752, https:\/\/doi.org\/10.1002\/clc.23212 (2019).","journal-title":"Clinical cardiology"},{"key":"65697_CR59","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1086\/688084","volume":"6","author":"H Gall","year":"2016","unstructured":"Gall, H. et al. An international physician survey of chronic thromboembolic pulmonary hypertension management. Pulmonary circulation 6, 472\u2013482, https:\/\/doi.org\/10.1086\/688084 (2016).","journal-title":"Pulmonary circulation"},{"key":"65697_CR60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijcard.2019.02.051","volume":"291","author":"MS Khan","year":"2019","unstructured":"Khan, M. S. et al. Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. International journal of cardiology 291, 134\u2013139, https:\/\/doi.org\/10.1016\/j.ijcard.2019.02.051 (2019).","journal-title":"International journal of cardiology"},{"key":"65697_CR61","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1253\/circj.CJ-19-0161","volume":"83","author":"G Zoppellaro","year":"2019","unstructured":"Zoppellaro, G. et al. Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension- A Systematic Review and Meta-Analysis. Circulation journal: official journal of the Japanese Circulation Society 83, 1660\u20131667, https:\/\/doi.org\/10.1253\/circj.CJ-19-0161 (2019).","journal-title":"Circulation journal: official journal of the Japanese Circulation Society"},{"key":"65697_CR62","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.healun.2015.10.030","volume":"35","author":"CB Wiedenroth","year":"2016","unstructured":"Wiedenroth, C. B. et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. The Journal of Heart and Lung Transplantation 35, 591\u2013596 (2016).","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"65697_CR63","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/eurheartj\/ehx530","volume":"38","author":"T Aoki","year":"2017","unstructured":"Aoki, T. et al. Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications. European heart journal 38, 3152\u20133159, https:\/\/doi.org\/10.1093\/eurheartj\/ehx530 (2017).","journal-title":"European heart journal"},{"key":"65697_CR64","doi-asserted-by":"publisher","first-page":"204589401878399","DOI":"10.1177\/2045894018783996","volume":"8","author":"CB Wiedenroth","year":"2018","unstructured":"Wiedenroth, C. B. et al. Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. Pulmonary circulation 8, 2045894018783996, https:\/\/doi.org\/10.1177\/2045894018783996 (2018).","journal-title":"Pulmonary circulation"},{"key":"65697_CR65","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12350-016-0598-9","volume":"24","author":"R Kalra","year":"2017","unstructured":"Kalra, R. et al. Conducting and interpreting high-quality systematic reviews and meta-analyses. Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology 24, 471\u2013481, https:\/\/doi.org\/10.1007\/s12350-016-0598-9 (2017).","journal-title":"Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology"},{"key":"65697_CR66","doi-asserted-by":"crossref","unstructured":"Thenappan, T., Ormiston, M. L., Ryan, J. J. & Archer, S. L. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ (Clinical research ed.) 360, j5492, 10.1136\/bmj.j5492 (2018).","DOI":"10.1136\/bmj.j5492"},{"key":"65697_CR67","unstructured":"UMIN-CTR Clinical Trial. Multicenter Randomized controlled trial based on Balloon Pulmonary Angioplasty for chronic thromboembolic pulmonary hypertension, https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000022608 (2019)."},{"key":"65697_CR68","unstructured":"ClinicalTrials.gov. Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension (RACE), https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02634203 (2019)."},{"key":"65697_CR69","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/CIRCULATIONAHA.109.865881","volume":"120","author":"KW Jensen","year":"2009","unstructured":"Jensen, K. W. et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 120, 1248 (2009).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65697-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65697-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65697-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:04:40Z","timestamp":1670328280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65697-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65697"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65697-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"25 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Thenappan receives modest consultation fees from Actelion and Gilead. We have no conflict of interests to declare other than Dr. Thenappan.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8870"}}